Goldman Sachs’s TRIVASCULAR TECHONOLOGIES, INC, COMMON STOCK TRIV Stock Holding History

Goldman Sachs’s Portfolio TRIV Stock Details TRIV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-34,310	Closed	-$228K	–	7609
2015 Q4	$228K	Sell	34,310 -98,804	-74%	-$655K	﹤0.01%	5593
2015 Q3	$666K	Buy	133,114 +72,116	+118%	+$387K	﹤0.01%	4869
2015 Q2	$326K	Buy	60,998 +17,608	+41%	+$125K	﹤0.01%	5650
2015 Q1	$455K	Sell	43,390 -1,398	-3%	-$14.4K	﹤0.01%	5234
2014 Q4	$563K	Sell	44,788 -1,188	-3%	-$16.2K	﹤0.01%	5175
2014 Q3	$666K	Buy	45,976 +3,701	+9%	+$53.7K	﹤0.01%	5017
2014 Q2	$658K	Buy	+42,275	New	+$642K	﹤0.01%	5082

Goldman Sachs's TRIV Position: Q1 2016 in Review

Goldman Sachs sold out of TRIVASCULAR TECHONOLOGIES, INC, COMMON STOCK (TRIV) in Q1 2016, closing a stake of 34,310 shares — an estimated $228K sold.

Goldman Sachs first reported a position in TRIV in Q2 2014 and held it in 7 quarters. The position peaked at $666K in Q3 2015. 0 funds tracked by Wall St. Rank hold TRIV as of Q1 2016.

Goldman Sachs reported no remaining TRIVASCULAR TECHONOLOGIES, INC, COMMON STOCK position as of Q1 2016 after selling out during the quarter.
Goldman Sachs sold 34,310 TRIVASCULAR TECHONOLOGIES, INC, COMMON STOCK shares in Q1 2016, an estimated $228K.
Goldman Sachs first reported a position in TRIVASCULAR TECHONOLOGIES, INC, COMMON STOCK in Q2 2014 and held it in 7 quarters.
Goldman Sachs's TRIVASCULAR TECHONOLOGIES, INC, COMMON STOCK position peaked at $666K in Q3 2015.
0 funds tracked by Wall St. Rank held TRIVASCULAR TECHONOLOGIES, INC, COMMON STOCK as of Q1 2016.

Based on Goldman Sachs's 13F filing for Q1 2016, filed 13 May 2016.